DOMINIC NKWOCHA: Open Payments
NPI 1942221718 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 30 payments from 10 companies in 2025. Trend: 2023 $279 · 2024 $4,378 · 2025 $623
Food & beverage: $617Education: $5
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $184 |
| Janssen Pharmaceuticals, Inc | 7 | $152 |
| Vanda Pharmaceuticals Inc. | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
Products named: REXULTI, SPRAVATO, ABILIFY ASIMTUFII, FANAPT, COBENFY, INVEGA SUSTENNA, UZEDY, Auvelity.
Industry payments across GA — which companies pay providers there.
